This protocol applies to patients with sarcoidosis who have anterior uveitis — inflammatory involvement of the front segment of the eye. Anterior uveitis is a recognised ocular complication of sarcoidosis that requires timely, directed management to control intraocular inflammation and prevent structural damage.
The approach centres on locally applied topical therapy directed at the eye. Eye drops targeting inflammation and eye drops addressing pain and the risk of intraocular scarring form the basis — though the complete regimen, specific agents, and full management sequence are detailed in the structured protocol.
Anterior uveitis usually can be managed with local therapy using corticosteroid eye drops to suppress inflammation and cycloplegic eye drops to suppress pain and avoid intraocular scarring.
View source ↗